Effect of N-terminal deletion on biological activity of vascular endothelial cell growth inhibitor

Acta Biochimica et Biophysica Sinica

Volumn 35, Issue 2, 2003, Pages 133-137

  Zhang, Min ^a   Wang, Lu ^a   Wang, Hong Wei ^a   Pan, Xin ^a   Pan, Wei ^a   Qi, Zhong Tian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biological activity; Endothelial cell; Expression; Mutants; VEGI

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOASSAY; BLOOD VESSEL; CAPILLARY; CELL GROWTH; ENDOTHELIUM CELL; ESCHERICHIA COLI; GENE DELETION; GROWTH INHIBITION; IC 50; INHIBITION KINETICS; MEMBRANE; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; UMBILICAL VEIN; WILD TYPE;

ALLANTOIS; AMINO ACID SEQUENCE; ANIMALS; CELL DIVISION; CELL LINE; CHICK EMBRYO; CHORION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; SEQUENCE ALIGNMENT; SEQUENCE DELETION; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0037257686     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Tan KB, Harrop J, Reddy M, Young P, Terrett J, Emerry J, Moore G et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene, 1997, 204(1-2): 35-46
2. Zhai Y, Ni J, Jiang GW, Lu J, Xing L, Lincoln C, Carter KC et al. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J, 1999, 13(1): 181-189
3. Yue TL, Ni J, Romanic AM, Gu JL, Keller P, Wang C, Kumar S et al. TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and P38 mitogen-activated protein kinase) and caspase-3-like protease. J Biol Chem, 1999, 274(3): 1479-1486
4. Zhai Y, Yu J, Iruela-Arispe L, Huang WQ, Wang Z, Hayes AJ, Lu J et al. Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEG1, a novel cytokine of the TNF superfamily. Int J Cancer, 1999, 82(1): 131-136
5. Yu J, Tians, Netheny-Baxlow L, Chew LJ, Hayes AJ, Pan H, Yu GI et al. Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor. Circ Res, 2001, 89(12): 1161-1167
6. Fu SF, Lu YL, Zhang CS, Chen K. Angiogenesis effect detected by chick chorioallantoic membrane (CAM) technique. Bull Acad Mil Med Sci, 1993, 17(4): 294-296
7. Ostade XV, Tavemier J, Fiers W. Structure-activity studies of human tumor necrosis factors. Protein Eng, 1994, 7(1): 5-22
8. Goh CR, Loh CS, Porter AG. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis beta (lymphotoxin). Protein Eng, 1991, 4(7): 785-791
9. Singh J, Garber E, Vlijmen HV, Karpusas M, Hsu YM, Zheng Z, Naismith JH et al. The role of polar interations in the molecular recognition of CD40L with its receptor CD40. Protein Science, 1998, 7(5): 1124-1135
10. 151, a novel vascular endothelial cell growth inhibitor. Acta Biochim Biophys Sin, 2000, 32(5): 485-489
11. Eck MJ, Sprang SR. The structure of tumor necrosis factor-α at 2.6 Å resolution. Implication for receptor binding. J Biol Chem, 1989, 264(29): 17595-17605
12. Eck MJ, Ultsch M, Rinderknecht E, Vos AM, Sprang S. The structure of human lymphotoxin at 1.9 Å resolution. J Biol Chem, 1992, 267(4): 2119-2122
13. Karpusas M, Hsu YM, Wang JH, Thompson J, Lederman S, Chess L, Thomas D. 2 Å crystal structure of an extracellular fragment of human CD40 ligand. Struture, 1995, 3(10): 1031-1039
14. Cha SS, Kim MS, Choi YH, Sung BJ, Shin NK, Shin HC, Sung YC et al. 2.8 Å resolution crystal struturc of human TRAIL, a cytokine with selective antitumor activity. Immunity, 1999, 11(2): 253-261